Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1988 1
1992 1
1994 1
1997 2
1998 2
2000 1
2001 4
2002 1
2003 5
2004 1
2005 2
2006 3
2007 6
2008 6
2009 9
2010 3
2011 5
2012 4
2013 8
2014 8
2015 9
2016 12
2017 21
2018 18
2019 12
2020 59
2021 51
2022 37
2023 17
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

213 results

Results by year

Filters applied: Meta-Analysis, Review, Systematic Review, in the last 10 years. Clear all
Page 1
The role of IgG Fc receptors in antibody-dependent enhancement.
Bournazos S, Gupta A, Ravetch JV. Bournazos S, et al. Nat Rev Immunol. 2020 Oct;20(10):633-643. doi: 10.1038/s41577-020-00410-0. Epub 2020 Aug 11. Nat Rev Immunol. 2020. PMID: 32782358 Free PMC article. Review.
Antibody-dependent enhancement (ADE) is a mechanism by which the pathogenesis of certain viral infections is enhanced in the presence of sub-neutralizing or cross-reactive non-neutralizing antiviral antibodies. ...
Antibody-dependent enhancement (ADE) is a mechanism by which the pathogenesis of certain viral infections is enhanced i
Antibody-dependent enhancement of coronavirus.
Wen J, Cheng Y, Ling R, Dai Y, Huang B, Huang W, Zhang S, Jiang Y. Wen J, et al. Int J Infect Dis. 2020 Nov;100:483-489. doi: 10.1016/j.ijid.2020.09.015. Epub 2020 Sep 11. Int J Infect Dis. 2020. PMID: 32920233 Free PMC article. Review.
Antibody-dependent enhancement (ADE) exists in several kinds of virus. ...
Antibody-dependent enhancement (ADE) exists in several kinds of virus. ...
Antibody-Dependent Enhancement (ADE) and the role of complement system in disease pathogenesis.
Thomas S, Smatti MK, Ouhtit A, Cyprian FS, Almaslamani MA, Thani AA, Yassine HM. Thomas S, et al. Mol Immunol. 2022 Dec;152:172-182. doi: 10.1016/j.molimm.2022.11.010. Epub 2022 Nov 10. Mol Immunol. 2022. PMID: 36371813 Free PMC article. Review.
Antibody-dependent enhancement (ADE) has been associated with severe disease outcomes in several viral infections, including respiratory infections. ...
Antibody-dependent enhancement (ADE) has been associated with severe disease outcomes in several viral infections, incl
Antibody-Dependent Enhancement: A Challenge for Developing a Safe Dengue Vaccine.
Shukla R, Ramasamy V, Shanmugam RK, Ahuja R, Khanna N. Shukla R, et al. Front Cell Infect Microbiol. 2020 Oct 22;10:572681. doi: 10.3389/fcimb.2020.572681. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 33194810 Free PMC article. Review.
These antibodies are generally cross-reactive among DENV serotypes carrying a higher risk of promoting Antibody-Dependent Enhancement (ADE). ADE is a phenomenon in which suboptimal neutralizing or non-neutralizing cross-reactive antibodies bind to virus and f …
These antibodies are generally cross-reactive among DENV serotypes carrying a higher risk of promoting Antibody-Dependent E
Dengue virus neutralizing antibody: a review of targets, cross-reactivity, and antibody-dependent enhancement.
Sarker A, Dhama N, Gupta RD. Sarker A, et al. Front Immunol. 2023 Jun 2;14:1200195. doi: 10.3389/fimmu.2023.1200195. eCollection 2023. Front Immunol. 2023. PMID: 37334355 Free PMC article. Review.
The antibody raised by the vaccine or the primary infections are frequently cross-reactive; however, weakly neutralizing, and during subsequent infection, they may increase the odds of antibody-dependent enhancement (ADE). Despite that, many neutralizing anti …
The antibody raised by the vaccine or the primary infections are frequently cross-reactive; however, weakly neutralizing, and during subsequ …
Antibody-Dependent Enhancement: "Evil" Antibodies Favorable for Viral Infections.
Yang X, Zhang X, Zhao X, Yuan M, Zhang K, Dai J, Guan X, Qiu HJ, Li Y. Yang X, et al. Viruses. 2022 Aug 8;14(8):1739. doi: 10.3390/v14081739. Viruses. 2022. PMID: 36016361 Free PMC article. Review.
However, in contrast with the neutralizing antibodies (NAbs), sub- or non-NAbs may facilitate the virus to enter the cells and enhance viral infection, which is termed antibody-dependent enhancement (ADE). The ADE of most virus infections is mediated by the F …
However, in contrast with the neutralizing antibodies (NAbs), sub- or non-NAbs may facilitate the virus to enter the cells and enhance viral …
Antibody-Dependent Enhancement with a Focus on SARS-CoV-2 and Anti-Glycan Antibodies.
Ziganshina MM, Shilova NV, Khalturina EO, Dolgushina NV, V Borisevich S, Yarotskaya EL, Bovin NV, Sukhikh GT. Ziganshina MM, et al. Viruses. 2023 Jul 20;15(7):1584. doi: 10.3390/v15071584. Viruses. 2023. PMID: 37515270 Free PMC article. Review.
Antibody-dependent enhancement (ADE) is a phenomenon where virus-specific antibodies paradoxically cause enhanced viral replication and/or excessive immune responses, leading to infection exacerbation, tissue damage, and multiple organ failure. ...
Antibody-dependent enhancement (ADE) is a phenomenon where virus-specific antibodies paradoxically cause enhanced viral
Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies.
Lee WS, Wheatley AK, Kent SJ, DeKosky BJ. Lee WS, et al. Nat Microbiol. 2020 Oct;5(10):1185-1191. doi: 10.1038/s41564-020-00789-5. Epub 2020 Sep 9. Nat Microbiol. 2020. PMID: 32908214 Review.
Data from the study of SARS-CoV and other respiratory viruses suggest that anti-SARS-CoV-2 antibodies could exacerbate COVID-19 through antibody-dependent enhancement (ADE). Previous respiratory syncytial virus and dengue virus vaccine studies revealed human …
Data from the study of SARS-CoV and other respiratory viruses suggest that anti-SARS-CoV-2 antibodies could exacerbate COVID-19 through a
Antibody-Dependent Enhancement of Bacterial Disease: Prevalence, Mechanisms, and Treatment.
Torres VVL, Coggon CF, Wells TJ. Torres VVL, et al. Infect Immun. 2021 Mar 17;89(4):e00054-21. doi: 10.1128/IAI.00054-21. Print 2021 Mar 17. Infect Immun. 2021. PMID: 33558319 Free PMC article. Review.
Antibody-dependent enhancement (ADE) of viral disease has been demonstrated for infections caused by flaviviruses and influenza viruses; however, antibodies that enhance bacterial disease are relatively unknown. ...
Antibody-dependent enhancement (ADE) of viral disease has been demonstrated for infections caused by flaviviruses and i
Evolving understanding of antibody-dependent enhancement (ADE) of SARS-CoV-2.
Yang Y, Xu F. Yang Y, et al. Front Immunol. 2022 Oct 18;13:1008285. doi: 10.3389/fimmu.2022.1008285. eCollection 2022. Front Immunol. 2022. PMID: 36330519 Free PMC article. Review.
However, there is no comprehensive and clear view of whether there will be Antibody-dependent enhancement (ADE). We review the latest relevant studies, hoping to explain the ADE of SARS-CoV-2 infection sometimes observed in some patients....
However, there is no comprehensive and clear view of whether there will be Antibody-dependent enhancement (ADE). We rev …
213 results